Clinical trial
Intra-operative Radiotherapy After Breast-conversing Surgery in Treating Women With Ductal Carcinoma in Situ Breast Cancer
NCT02389673 is registered in ClinicalTrials.gov with Liao Ning as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intra-operative Radiotherapy After Breast-conversing Surgery in Treating Women With Ductal Carcinoma in Situ Breast Cancer
- Lead sponsor
- Liao Ning
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2014
- Completion date
- June 30, 2026
- Enrollment
- 222 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.